Behavioral Intervention

Abstract

This edition of Medicine Matters highlights a recent Perspective in JAMA, titled Respriatory Virus Vaccines: Restoring Confidence and Trust." I co-authored this with Andrea Garcia from the American Medical Association (AMA), Dr Michael Osterholm from the Vaccine Integrity Project (VIP) and the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP), and Dr Rochelle Walensky, from VIP, CIDRAP, and Harvard Medical School and former CDC Director. To address that, we have now an exciting new collaboration between the AMA, the VIP at the University of Minnesota, and four medical specialty societies: the American Academy of Pediatrics, American College of Obstetricians and Gynecologists, American Academy of Family Physicians, and Infectious Diseases Society of America. This shakeup led to a resolution at the AMA's House of Delegates meeting in June 2025, demanding action to restore ACIP to its former glory in the long term — but in the interim, to support only previous ACIP recommendations as of May 1, 2025, or vaccine recommendations from national medical specialty societies. And there's great news for those who choose to save time and get several shots at one visit: The VIP review of new evidence did not show any new safety concerns when giving flu shots at the same time as COVID and RSV vaccines."

Abstract

Across Europe, cases of congenital syphilis nearly doubled in just one year, from 78 in 2023 to 140 in 2024, in 14 countries reporting data. In contrast, Denmark has marked 10 years without a single case of vertical syphilis transmission from mother to child since 2016. The main reason for this achievement is that, since 2010, Denmark has offered universal syphilis screening to pregnant women free of charge as part of a comprehensive prenatal care program. General practitioners implement the screening, which usually takes place during the first prenatal visit.

Abstract

Among the perceived causes are a lower perception of risk, the phenomenon of chemsex — which, although more prevalent in certain groups, is spreading to other segments of the population — and the use of dating apps that facilitate having multiple sexual partners in a short period of time said Infante. Given that the increase in STIs begins at age 15 and that many of these minors do not have a primary care pediatrician, it is worth asking how to address sexuality with a minor who comes to the clinic and may need help in this regard. For minors between the ages of 12 and 16, the law recognizes the concept of a "mature minor," and the physician must assess their intellectual and emotional capacity to understand the implications of the decision, Infante noted. Taking this framework into account and applying it to the reality of the doctor's office, Infante emphasized that a fundamental aspect is the right to confidentiality: Minors, especially those 16 years or older, have the right to keep their parents from being informed about their sexual health consultations if the doctor determines that this protects the minor's best interests and their right to health."

Abstract

US President Donald Trump recently signed an executive order aimed at reducing the number of routine childhood vaccinations in the United States and replacing combined vaccines for measles, mumps and rubella (MMR) with separate single-antigen vaccines for the three conditions. While the European Medicines Agency (EMA) does not usually comment on vaccination policy decisions taken outside the European Union (EU) or European Economic Area (EEA), this recent development in the US will undoubtedly influence public debate in Europe and elsewhere in the world. In an increasingly interconnected world, it is no surprise that decisions on vaccines in one jurisdiction can affect public attitudes in others.

Abstract

Flere resistente gonorrébakterier Den nye opgørelse viser samtidig ændringer i gonorrébakteriernes resistens over for antibiotika.Gonorrébakterien har gennem tiden udviklet resistens over for flere antibiotika, og i enkelte tilfælde erhvervet i udlandet har SSI nu også fundet resistens mod det antibiotikum, der normalt bruges mod gonorré i Danmark. Analyser af bakteriernes DNA viser, at de tre tilfælde ikke er beslægtede, og SSI har ikke konstateret tegn på, at de resistente gonokokker har spredt sig videre i Danmark. Fakta om gonorré i 2025 Der blev registreret 5.134 gonorrétilfælde i Danmark 3.747 tilfælde blev registreret blandt mænd og 1.387 blandt kvinder Der blev gennemført 343.224 testepisoder Forekomsten steg fortsat blandt mænd, der har sex med mænd, mens der var tegn på stabilisering blandt heteroseksuelle I 8 procent af de tilfælde, hvor smitteland var oplyst, var smitten erhvervet i udlandet To tilfælde med ceftriaxon-resistente gonokokker blev fundet i 2025. Det er især i Cambodja og Vietnam, at sådanne gonokokker findes Der er ikke konstateret videre spredning i Danmark af de tre ceftriaxon-resistente gonokokstammer Den samlede testaktivitet faldt i 2025, hvor der blev gennemført omkring seks procent færre testepisoder end året før, mens positivraten steg en smule